Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 617-365-2 | CAS number: 82597-69-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1995-09-25 to 1985-12-19
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- reaction mass of (1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylic acid and (1S,3S)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylic acid
- EC Number:
- 614-283-9
- Cas Number:
- 68127-59-3
- Molecular formula:
- C9H10ClF3O2
- IUPAC Name:
- reaction mass of (1R,3R)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylic acid and (1S,3S)-3-[(1Z)-2-chloro-3,3,3-trifluoroprop-1-en-1-yl]-2,2-dimethylcyclopropanecarboxylic acid
- Details on test material:
- - Physical state: solid
- Colour: white
- Purity test date: 1995-09-05
- Expiration date of the lot/batch: test material used within the stated expiry date (information supplied by sponsor)
- Stability under test conditions: stability and achieved concentrations in the vehicles used were not determined by analysis
- Storage condition of test material: at ambient temperature in the dark
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: human, one male and one female donor
- Details on mammalian cell type (if applicable):
- - Blood donors: donor 1 (male), donor 2 (female), both with previously established low incidence of chromosomal aberration in their lymphocytes
- Source of lymphocytes: peripheral human blood, obtained by venipuncture on the day of culture, 0.5 mL per culture (10 mL)
- Mean cell cycle time of lymphocytes: 13.5 hours, determined in test laboratory 1992-09 and 1993-11
- Type and identity of media: RPMI-1640 (Dutch Modification) culture medium, supplemented with 10% fetal bovine serum, 1.0 IU/mL heparin, 100 IU/mL penicillin and 100 microgram/mL streptomycin; stimulated with mitogen: phytohaemagglutinin M Form (PHA)
- Properly maintained: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/naphthoflavone-induced Sprague-Dawley rat liver S9 fraction, 25% w/v homogenate; co-factor stock: glucose-6-phosphate (7.5mM) and NADP (6 mM). 200 microliter of a 1:1 mix of S9 and cofactor stock solution added to each culture (10 mL).
- Test concentrations with justification for top dose:
- Mitotic index determination without S9 mix, 68 hour sampling time: donor 1: 5000, 1000, 500, 200, 100, 50, 10, 5 microgram/mL, donor 2: 500, 350, 200, 150, 100, 50, 20, 10 microgram/mL
Mitotic index determination with S9 mix, 68 hour sampling time: donor 1 + 2: 1000, 850, 700, 500, 350, 200, 100, 50, microgram/mL
Mitotic index determination without S9 mix, 92 hour sampling time: donor 2: 500, 350, 200, 150 microgram/mL
Mitotic index determination with S9 mix, 92 hour sampling time: donor 2: 1000, 850, 700, 500 microgram/mL
Chromosomal aberration determination without S9 mix, 68 hour sampling time: donor 1: 200, 100, 10 microgram/mL, donor 2: 200, 100, 20 microgram/mL
Chromosomal aberration determination with S9 mix, 68 hour sampling time: donor 1 + donor 2: 1000, 500, 100 microgram/mL
Chromosomal aberration determination without S9 mix, 92 hour sampling time: donor 2: 200 microgram/mL
Chromosomal aberration determination with S9 mix, 92 hour sampling time: donor 2: 1000microgram/mL
All concentrations refer to the weight of the test material, not corrected for purity - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO (100 microliter/10 mL culture medium)
- Justification for choice of solvent/vehicle: solubility of test substance and positive control substances
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- performed, but no results reported
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO 10 microliter/mL, in duplicate per donor and time point
- Positive controls:
- yes
- Remarks:
- 0.2 microgram/mL, one culture per donor, 68 hours sampling time only
- Positive control substance:
- mitomycin C
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Remarks:
- performed, but no results reported
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO 10 microliter/mL, in duplicate per donor and time point
- Positive controls:
- yes
- Remarks:
- 50 microgram/mL, one culture per donor, 68 hours sampling time only
- Positive control substance:
- cyclophosphamide
- Remarks:
- with metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
INCUBATION TEMPERATURE: 37 °C
DURATION
- Preincubation period: 48 hours, then change to fresh medium
- Exposure duration: without S9-mix: 20 h (24 h for 92-h harvesting time), with S9-mix: 3 h
- Fixation time (start of exposure up to fixation or harvest of cells): 20 h (for 68-h harvesting time), 44 h (for 92-h harvesting time, with fresh medium at 72 hours total culture time)
SPINDLE INHIBITOR (cytogenetic assays): colcemid (0.4 microgram/mL), at 66 or 90 hours of culture
HARVESTING:
- centrifugation (400 g, 5 min) at 68 or 92 hours
- Hypotonic treatment: 0.075 M KCl, 10 min at room temperature
- Fixation: methanol/glacial acetic acid (3:1 v/v), three times
STAIN (for cytogenetic assays): 10% solution of Giemsa stain, buffered to pH 6.8; time: 7 minutes
- Slides mounted in DPX
NUMBER OF REPLICATIONS:
- Two independent tests with lymphocytes from different donors (one male, one female)
- Two cultures per donor, concentration, and harvesting time, in the presence and absence of metabolic activation
- Four slides per culture
NUMBER OF CELLS EVALUATED:
- For mitotic index: 1000 lymphocytes per culture
- For aberration counting: 100 cells in metaphase per culture, i.e. 200 per donor, concentration, and harvesting time
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Chromosomal damage criteria according to: Scott D et al, Metaphase Chromosome Aberration Assays in vitro, in: Kirkland DJ (ed.): Basic Mutagenicity Tests: UKEMS Recommended Procedures; Cambridge University Press, Cambridge 1990
- Determination of polyploidy and endoreplication: Not explicitly reported, probably performed due to guideline requirements
- Determination of osmolality of the culture medium as a function of test substance concentration
- Determination of pH of the culture medium as a function of test substance concentration - Evaluation criteria:
- Positive response:
- statistically (p<0.01) and biologically significant increase in the percentage of aberrant cells, compared with the solvent controls - Statistics:
- - Calculation of mean percent mitotic index
- Calculation of mean percent aberrant cells (excluding gaps)
- Fisher's exact test (one-sided) to determine statistically significant increases
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- lymphocytes: human, one male and one female donor
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- lymphocytes: human, one male and one female donor
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Remarks:
- at 68 h sampling time (donors 1+2) and 92 h sampling time (only female donor tested)
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: The acidic test substance reduced the pH of the culture medium over the concentration range tested, but at the concentrations selected for chromosomal aberration (CA) analysis, these pH reductions were not significant (7.79 in the solvent control vs 7.45 at the highest dose).
- Effects of osmolality: Addition of the test material to the culture medium (up to 5000 microgram/mL) had no significant effect on osmolality (control 447 mmol/kg, highest dose 427 mmol/kg)
- Evaporation from medium: test material is non-volatile
- Water solubility and precipitation: No precipitation observed up to 5000 microgram/mL
- Other confounding effects: none observed
RANGE-FINDING/SCREENING STUDIES: none
COMPARISON WITH HISTORICAL CONTROL DATA: not reported
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Significant reduction of mean mitotic index at 200 microgram/mL (60% in male donor, 46% in female donor), which is the highest concentration used for CA analysis in the absence of metabolic activation (- S9-mix)
- Significant reduction of mean mitotic index at 1000 microgram/mL (58% in male donor, 56% in female donor), which is the highest concentration used for CA analysis in the presence of metabolic activation (+ S9-mix) - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'. Remarks: at 68 h sampling time (donors 1+2) and 92 h sampling time (only female donor tested)
Any other information on results incl. tables
Table 1: Chromosomal Aberrations and Mitotic Index (Mean Percentage of Total Cells Analysed)
Metabolic activation | Sampling time (h) | Donor | Treatment | Mean % Aberrant cells § | Aberrations / cell § | Mean % Mitotic index | |
- S9 | 68 | 1 | DMSO | 10 microliter/mL | 1.00 | 0.010 | 9.8 |
Mitomycin C # | 0.2 microgram/mL | 29.00** | 0.340 | 5.3 | |||
Test material | 200 microgram/mL | 1.00 | 0.010 | 3.9 | |||
100 microgram/mL | 2.50 | 0.025 | 7.9 | ||||
10 microgram/mL | 1.50 | 0.015 | 9.2 | ||||
- S9 | 68 | 2 | DMSO | 10 microliter/mL | 1.50 | 0.015 | 11.5 |
Mitomycin C # | 0.2 microgram/mL | 23.00** | 0.280 | 6.7 | |||
Test material | 200 microgram/mL | 3.50 | 0.035 | 6.2 | |||
100 microgram/mL | 4.50 | 0.045 | 8.5 | ||||
10 microgram/mL | 4.00 | 0.045 | 9.8 | ||||
- S9 | 92 | 2 | DMSO | 10 microliter/mL | 2.00 | 0.025 | 13.2 |
Test material | 200 microgram/mL | 2.50 | 0.030 | 9.3 | |||
+ S9 | 68 | 1 | DMSO | 10 microliter/mL | 0.00 | 0.000 | 14.4 |
Cyclophosphamide # | 50 microgram/mL | 26.00** | 0.340 | 5.9 | |||
Test material | 1000 microgram/mL | 1.50 | 0.015 | 6.0 | |||
500 microgram/mL | 1.50 | 0.015 | 10.0 | ||||
100 microgram/mL | 1.00 | 0.015 | 10.9 | ||||
+ S9 | 68 | 2 | DMSO | 10 microliter/mL | 4.50 | 0.045 | 13.8 |
Cyclophosphamide # | 50 microgram/mL | 29.00** | 0.400 | 6.0 | |||
Test material | 1000 microgram/mL | 3.50 | 0.045 | 6.1 | |||
500 microgram/mL | 4.00 | 0.050 | 8.3 | ||||
100 microgram/mL | 1.50 | 0.015 | 9.9 | ||||
+ S9 | 92 | 2 | DMSO | 10 microliter/mL | 2.50 | 0.030 | 15.1 |
Test material | 1000 microgram/mL | 2.00 | 0.020 | 9.8 |
§ Excluding gaps
# positive control values determined from a single culture
** Statistically significant increase in chromosomal damage, p<0.01
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
The test material was found to be non-clastogenic to cultured human lymphocytes in vitro, in the presence or absence of metabolic activation (S9-mix) under the conditions of the assay. The study report is relevant, reliable and adequate for risk assessment, classification and labeling. - Executive summary:
The clastogenic potential of the test substance was assessed according to OECD 473 (chromosome aberration, CA), in human lymphocytes from two donors (male and female), treated in vitro with a range of concentrations of the test material, in the presence and absence of a rat liver-derived metabolic activation system (S9-mix). Cultures were harvested at the standard time of 68 hours after culture initiation, and additional cultures from the female donor were harvested at 92 hours.
Test material concentrations ranged from 5 to 5000 microgramg/mL (with and without S9-mix), to determine mitotic activity, which showed a dose-related reduction under all conditions tested. CA was assessed at three test material concentrations; the highest concentration was chosen to show a significant reduction of the mitotic index: For the 68-hours sampling time, in the absence of S9-mix, cultures treated with 10 or 20 (for male and female donor, respectively), 100, and 200 microgram/mL were selected, whereas in the presence of S9-mix, 100, 500, and 1000 microgram/mL were applied. For the 92-hour sampling (female donor only), 200 and 1000 microgram/mL (without and with S9 -mix) were analyzed. The sensitivity of the test system and the activity of the S9-mix were tested with positive control agents, mitomycin C (- S9 -mix) and cyclophosphamide (+ S9 -mix). Influences of the test material on the pH and osmolality of the culture medium were measured and found to be insignificant.
Both control agents induced highly significant positive results and thus established the validity of the test system. No statistically or biologically significant increases in the percentage of aberrant cells, compared to the solvent control values, were recorded in the two independent experiments (with lymphocytes from either donor), at any concentration or time point, neither in the presence nor in the absence of S9-mix. It is therefore concluded that, under the conditions of this assay, the test material is not clastogenic to cultured human lymphocytes in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.